Taking the longer term view and considering everything we learnt from the recent investor update webinar, I'm thinking the following:
Azer Cell is now our best chance of getting a significant commercial outcome It will cost $30 Million US to complete the phase 2/3 trail It will take up to 3 years. Value of Azer Cell with FDA approval has to be 1-2 Billion US IMO
So a cost of $30 Million US to achieve a value of 1-2 billion US in 3 years is worth the risk to me. I've now reset my expectations and am prepared to wait for 3 years based on the above and that's putting no value on the rest of the platform.
I assume the BOD tried to negotiate partnership deals but obviously they didn't want to give away too much upside.
We also must be due the R&D rebate soon which could be more than $20 Million.
All IMO.
IMU Price at posting:
1.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)